Survodutide – Dual Receptor Agonist Peptide (12 mg Lyophilized Powder)

Product Overview

Survodutide is a synthetic, long-acting dual receptor agonist peptide supplied in a 12 mg lyophilized vial. It is designed exclusively for in vitro laboratory studies, including receptor interaction modeling, conformational analysis, and pharmacokinetic simulations. Produced under controlled lab conditions, each batch undergoes third-party validation for purity and sequence integrity.

This material is not intended for human or veterinary use, and no therapeutic or diagnostic claims are associated with this product.

Key Specifications

Research Applications

Survodutide is used under controlled non-clinical protocols, including:

• Receptor Binding Studies: Evaluation of dual agonist mechanisms and receptor pathway activation
• Pharmacokinetic Modeling: Stability, half-life, and degradation tracking in vitro
• Peptide Structure Characterization: Folding dynamics, binding conformations, and sequence-behavior mapping

All applications are investigational and confined to lab settings. Not for clinical trial use.

Handling & Lab Use Guidelines

• Store lyophilized vials at –20 °C in dry, sealed containers
• Reconstitute only in a sterile laboratory setting
• Avoid repeated freeze–thaw cycles after reconstitution
• Label and log all handling per institutional SOPs

Compliance & Safety Notice

• This product is not a dietary supplement or drug
• It is not intended for ingestion, injection, or application in any living subject
• Use restricted to qualified laboratories in accordance with HVY Research’s Research Use Policy

Disclaimer

Survodutide is intended exclusively for laboratory research and is not approved by the FDA for any therapeutic, diagnostic, or medical application. Use outside controlled lab protocols voids all warranties and violates federal regulations. By purchasing, you certify lawful use under appropriate institutional oversight.